anxietytobaccouse40-70 y.o.,ASCVD ≥10%, lowbleeding risk40-59 y.o.,ASCVD ≥10%, lowbleeding riskcardiovasculardiseaseFractureRiskAssessmentToolGailmodeldiabetes3%PREVENTequation40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsTyrer-Cuzickmodelq1ymammogramcommunity-dwelling,postmenopausalwomenTimedup andgo testlungcancerstatincervicalcancer65y.o.multidoseinitial series,then 1 doseat 2-6monthsinsufficientevidenceforscreeningherpeszosterHepatitisBdyslipidemiadementia50y.o.depression≥20%2 doses,2-6monthsapartq15yhormonetherapypneumococcalaspirinhypertension1 dose; 2doses (2-6monthsapart) ifimmunocomp≤q2y≥ 140mg/dLHepatitisC≥ 200mg/dL75y.o.≥ 100mg/dL≥6.5%HIVq2yq5y≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor≥ 126mg/dLraloxifenewomenage 55-64 y.o.overweight/ obesitytamoxifen60y.o.q1yaromataseinhibitors40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factor40y.o.ovariancancercolorectalcancerq1-2ymammogrambased on lifeexpectancy /health status< 60y.o.breastcancer52y.o.≥5.7%q3yanxietytobaccouse40-70 y.o.,ASCVD ≥10%, lowbleeding risk40-59 y.o.,ASCVD ≥10%, lowbleeding riskcardiovasculardiseaseFractureRiskAssessmentToolGailmodeldiabetes3%PREVENTequation40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsTyrer-Cuzickmodelq1ymammogramcommunity-dwelling,postmenopausalwomenTimedup andgo testlungcancerstatincervicalcancer65y.o.multidoseinitial series,then 1 doseat 2-6monthsinsufficientevidenceforscreeningherpeszosterHepatitisBdyslipidemiadementia50y.o.depression≥20%2 doses,2-6monthsapartq15yhormonetherapypneumococcalaspirinhypertension1 dose; 2doses (2-6monthsapart) ifimmunocomp≤q2y≥ 140mg/dLHepatitisC≥ 200mg/dL75y.o.≥ 100mg/dL≥6.5%HIVq2yq5y≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor≥ 126mg/dLraloxifenewomenage 55-64 y.o.overweight/ obesitytamoxifen60y.o.q1yaromataseinhibitors40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factor40y.o.ovariancancercolorectalcancerq1-2ymammogrambased on lifeexpectancy /health status< 60y.o.breastcancer52y.o.≥5.7%q3y

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. anxiety
  2. tobacco use
  3. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  4. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  5. cardiovascular disease
  6. Fracture Risk Assessment Tool
  7. Gail model
  8. diabetes
  9. 3%
  10. PREVENT equation
  11. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  12. Tyrer-Cuzick model
  13. q1y mammogram
  14. community-dwelling, postmenopausal women
  15. Timed up and go test
  16. lung cancer
  17. statin
  18. cervical cancer
  19. 65 y.o.
  20. multidose initial series, then 1 dose at 2-6 months
  21. insufficient evidence for screening
  22. herpes zoster
  23. Hepatitis B
  24. dyslipidemia
  25. dementia
  26. 50 y.o.
  27. depression
  28. ≥ 20%
  29. 2 doses, 2-6 months apart
  30. q15y
  31. hormone therapy
  32. pneumococcal
  33. aspirin
  34. hypertension
  35. 1 dose; 2 doses (2-6 months apart) if immunocomp
  36. ≤ q2y
  37. ≥ 140 mg/dL
  38. Hepatitis C
  39. ≥ 200 mg/dL
  40. 75 y.o.
  41. ≥ 100 mg/dL
  42. ≥ 6.5%
  43. HIV
  44. q2y
  45. q5y
  46. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  47. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  48. ≥ 126 mg/dL
  49. raloxifene
  50. women age 55-64 y.o.
  51. overweight / obesity
  52. tamoxifen
  53. 60 y.o.
  54. q1y
  55. aromatase inhibitors
  56. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  57. 40 y.o.
  58. ovarian cancer
  59. colorectal cancer
  60. q1-2y mammogram based on life expectancy / health status
  61. < 60 y.o.
  62. breast cancer
  63. 52 y.o.
  64. ≥ 5.7%
  65. q3y